Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. De Stefano · SciRah

Researcher profile · Semantic Scholar

V. De Stefano

Share profile

V. De Stefano — researcher profile on SciRah

h-index: 73
Works: 600
Citations: 21K

Most-cited papers

LocoMMotion: a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma – 2-year follow-up (final analysis)
M. Mateos, K. Weisel, V. De Stefano, H. Goldschmidt +19 more
2024Leukemia46 citations Open access
Semantic Scholar
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.
T. Barbui, A. Vannucchi, V. De Stefano, A. Carobbio +34 more
2023NEJM Evidence44 citations Open access
Semantic Scholar
A globally applicable “triple A” risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count
A. Tefferi, G. G. Loscocco, F. Farrukh, N. Szuber +10 more
2023American journal of hematology/oncology42 citations Open access
Semantic Scholar
Thrombosis in myeloproliferative neoplasms: a viewpoint on its impact on myelofibrosis, mortality, and solid tumors
T. Barbui, A. Ghirardi, A. Carobbio, V. De Stefano +3 more
2024Blood Cancer Journal35 citations Open access
Semantic Scholar
Identifying Patients with Polycythemia Vera at Risk of Thrombosis after Hydroxyurea Initiation: The Polycythemia Vera—Advanced Integrated Models (PV-AIM) Project
S. Verstovsek, I. Krečak, F. Heidel, V. De Stefano +11 more
2023Biomedicines31 citations Open access
Semantic Scholar
Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma
P. Moreau, N. V. van de Donk, M. Delforge, H. Einsele +18 more
2023Advances in Therapy26 citations Open access
Semantic Scholar
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes
T. Barbui, A. Carobbio, V. De Stefano, A. Álvarez-Larrán +37 more
2023Annals of Hematology21 citations Open access
Semantic Scholar
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial
Bianca Rocca, A. Tosetto, G. Petrucci, Elena Rossi +25 more
2024American journal of hematology/oncology20 citations Open access
Semantic Scholar
Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
P. Moreau, María-Victoria Mateos, M. E. González García, H. Einsele +25 more
2023Advances in Therapy18 citations Open access
Semantic Scholar
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real‐world setting: Interim results of the Italian observational study (ROMEI)
M. Breccia, F. Palandri, M. Martelli, F. Mendicino +52 more
2025Cancer17 citations Open access
Semantic Scholar
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab‐Refractory Multiple Myeloma Patients: A Multicenter Real‐World Study
E. Martino, D. Derudas, Elena Rossi, P. Stefanoni +38 more
2025Hematological Oncology16 citations Open access
Semantic Scholar
Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach
A. Carobbio, A. Vannucchi, E. Rumi, V. De Stefano +9 more
2023Blood Cancer Journal16 citations Open access
Semantic Scholar
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial
M. Mazzucconi, Francesco Rodeghiero, Giuseppe Avvisati, V. De Stefano +36 more
2024Blood Advances15 citations Open access
Semantic Scholar
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study
F. Palandri, E. Rossi, G. Auteri, M. Breccia +33 more
2023Cancers15 citations Open access
Semantic Scholar
Neutrophil-to-Lymphocyte ratio as surrogate for JAK2V617F suppression and event-free survival in polycythemia vera
T. Barbui, A. Ghirardi, V. Empson, Francesca Fenili +12 more
2025Blood Cancer Journal14 citations Open access
Semantic Scholar
Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives
M. Breccia, F. Palandri, N. Polverelli, Morena Caira +3 more
2024Frontiers in Oncology14 citations Open access
Semantic Scholar
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
J. Kiladjian, F. Marín, H. Al-Ali, A. Álvarez-Larrán +37 more
2024Annals of Hematology14 citations Open access
Semantic Scholar
Neutrophil/lymphocyte ratio identifies low‐risk polycythaemia vera patients for early Ropeginterferon alfa‐2b therapy
T. Barbui, A. Carobbio, P. Guglielmelli, A. Ghirardi +7 more
2024British Journal of Haematology13 citations
Semantic Scholar
Effect of daratumumab on stem cell yields in patients with newly diagnosed multiple myeloma: a report from the Multiple Myeloma Group
F. Fazio, M. Passucci, J. Micozzi, F. Di Landro +18 more
2024Bone Marrow Transplantation13 citations Open access
Semantic Scholar
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real‐life setting: An Italian MYNERVA Project
G. Coltro, Emanuela Sant'Antonio, G. Palumbo, F. Mannelli +17 more
2023Cancer Medicine13 citations Open access
Semantic Scholar
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate
C. Napodano, G. Ciasca, P. Chiusolo, K. Pocino +15 more
2023International Journal of Molecular Sciences12 citations Open access
Semantic Scholar
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea
F. Palandri, M. Breccia, E. Elli, R. Latagliata +14 more
2025Leukemia11 citations Open access
Semantic Scholar
Facts and Misfacts on D‐Dimer Testing. Consensus Guidance From the Italian Society on Thrombosis and Hemostasis (SISET)
A. Tripodi, W. Ageno, Luca Barcella, A. Coppola +8 more
2025American journal of hematology/oncology11 citations Open access
Semantic Scholar
Incidence of blast phase in myelofibrosis according to anemia severity
B. Mora, M. Maffioli, E. Rumi, P. Guglielmelli +21 more
2023eJHaem11 citations Open access
Semantic Scholar
Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.
Barbara Mora, F. Palandri, Paola Guglielmelli, Andrew T. Kuykendall +34 more
2026Blood10 citations Open access
Semantic Scholar
Age-stratified analysis reveals arterial thrombosis as a predictor for gender-related second cancers in myeloproliferative neoplasms: a case-control study
A. Ghirardi, A. Carobbio, P. Guglielmelli, A. Rambaldi +4 more
2024Blood Cancer Journal10 citations Open access
Semantic Scholar
Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study
A. Theocharides, H. Gisslinger, V. De Stefano, V. Accurso +14 more
2023European Journal of Haematology9 citations Open access
Semantic Scholar
Long-Term Survival with Multiple Myeloma: An Italian Experience
F. Fazio, Martina Gherardini, Elena Rossi, T. Zà +22 more
2025Cancers7 citations
Semantic Scholar
Real‐world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study
E. Lucchini, N. Vianelli, U. Consoli, G. Carli +30 more
2025British Journal of Haematology7 citations
Semantic Scholar
Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinion
A. Lucchesi, B. Fattizzo, V. De Stefano, M. Ruggeri +4 more
2023Therapeutic Advances in Hematology7 citations Open access
Semantic Scholar
Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data
E. Martino, A. Pitino, M. Offidani, R. Della Pepa +61 more
2025Haematologica6 citations Open access
Semantic Scholar
Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials
E. Martino, D. Derudas, Elena Rossi, S. Terlizzi +69 more
2024Haematologica6 citations Open access
Semantic Scholar
Evans syndrome: Disease awareness and clinical management in a nation‐wide ITP‐NET survey
B. Fattizzo, Valentina Carrai, M. Crugnola, E. Baldacci +27 more
2024European Journal of Haematology6 citations Open access
Semantic Scholar
Preliminary Safety and Efficacy of Navitoclax Plus Ruxolitinib in Janus Kinase Inhibitor‐Naïve Patients With Myelofibrosis From the Multicenter, Open‐Label, Phase 2 Study (REFINE)
Francesco Passamonti, James M. Foran, Anand Tandra, V. De Stefano +13 more
2026Hematological Oncology5 citations Open access
Semantic Scholar
Prediction of resistance to hydroxyurea therapy in patients with polycythemia vera: a machine learning study (PV-AIM) validated in a prospective interventional phase IV trial (HU-F-AIM)
F. Heidel, V. De Stefano, M. Zaiss, J. Kisro +8 more
2025Leukemia5 citations Open access
Semantic Scholar
Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study design
V. De Stefano, F. Passamonti, F. Palandri, F. Ramundo +28 more
2025Annals of Hematology5 citations Open access
Semantic Scholar
ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options
J. Kiladjian, F. Ferrer-Marín, H. Al-Ali, A. Álvarez-Larrán +37 more
2024Blood5 citations
Semantic Scholar
Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies
E. Maiolo, S. Bellesi, Fabrizia Campana, C. Iacovelli +11 more
2024Cancers5 citations
Semantic Scholar
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry
S. Bellesi, G. Schiaffini, Andrea Contegiacomo, E. Maiolo +13 more
2024Cytometry. Part B, Clinical cytometry5 citations
Semantic Scholar
Belantamab mafodotin in triple‐refractory multiple myeloma patients: A retro‐prospective observational study in Italy
F. Fazio, Maria Teresa Petrucci, L. Corvatta, A. Piciocchi +16 more
2024eJHaem4 citations Open access
Semantic Scholar
The impact of education on patients’ psycho-emotional status during allogeneic hematopoietic stem cell transplantation: a multicenter prospective study by thes Gruppo Italiano Trapianto di Midollo Osseo
M. Cioce, I. Borrelli, L. Cappucciati, Manuela Giori +16 more
2023Journal of psychosocial oncology4 citations
Semantic Scholar
Add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: a randomized phase 3 study
J. Kiladjian, U. Borate, E. Abruzzese, V. De Stefano +12 more
2026The Oncologist3 citations Open access
Semantic Scholar
The impact of daratumumab-containing induction on stem cell mobilization, collection and engraftment in newly diagnosed multiple myeloma: results of the prospective DILEMMA study
C. Valentini, Claudio Pellegrino, P. Chiusolo, Elena Rossi +6 more
2025Haematologica3 citations Open access
Semantic Scholar
Etentamig plus pomalidomide-dexamethasone combination therapy in relapsed or refractory multiple myeloma: A phase 1b dose-escalation and safety expansion study
Peter M. Voorhees, Anita D'Souza, H. Quach, Sabine Gaerditz +26 more
2025Blood3 citations
Semantic Scholar
Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients
Douglas Tremblay, Amica Ko, Pavlina Chrysafi, Chi-Joan How +39 more
2025Blood3 citations
Semantic Scholar
Thrombotic events after vaccination for covid-19 in Italy: a report from the Italian society on thrombosis and haemostasis registry
M. Donadini, Elisa Tarasconi, L. Bertù, E. Antonucci +8 more
2025Internal and Emergency Medicine3 citations Open access
Semantic Scholar
Genomic Testing in Adults With Undiagnosed Rare Conditions: Improvement of Diagnosis Using Clinical Exome Sequencing as a First‐Tier Approach
Roberta Petillo, Ilaria De Maggio, C. Piscopo, M. Chetta +30 more
2025Clinical Genetics3 citations
Semantic Scholar
Personalized Transplant Decision Making for Myelofibrosis in the Era of Molecular Genetics and JAK Inhibition
N. Gagelmann, Barbara Mora, F. Branzanti, A. Vannucchi +48 more
2024Blood3 citations
Semantic Scholar
Prescribing patterns and clinician preferences for direct oral anticoagulant use in unusual site venous thromboembolism: a cross-sectional analysis from the Direct oral anticoagulants in Unusual Site venous Thromboembolism (DUST) study
N. Riva, L. Bertoletti, A. Chistolini, V. De Stefano +21 more
2026Research and Practice in Thrombosis and Haemostasis2 citations Open access
Semantic Scholar
Improving the management of Polycythemia Vera patients eligible for cytoreduction: report of a multidisciplinary advisory board
F. Ramundo, Elena Rossi, K. Peris, A. Pontecorvi +4 more
2025Current Medical Research and Opinion2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Palandri×17
Invite
F. Palandri — researcher profile on SciRah
A. Vannucchi×16
Invite
A. Vannucchi — researcher profile on SciRah
P. Guglielmelli×11
Invite
P. Guglielmelli — researcher profile on SciRah
Elena Rossi×11
Invite
Elena Rossi — researcher profile on SciRah

×9

Invite

A. Iurlo — researcher profile on SciRah

Invite

G. Carli — researcher profile on SciRah

J. Kiladjian×8

Invite

J. Kiladjian — researcher profile on SciRah

Invite

E. Elli — researcher profile on SciRah

Invite

A. Carobbio — researcher profile on SciRah

Invite

E. Rumi — researcher profile on SciRah

G. G. Loscocco×7

Invite

G. G. Loscocco — researcher profile on SciRah

Invite

S. Betti — researcher profile on SciRah